Cyanopyrimidine derivative
US9708292B2 · kind B2 · utility
0Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2010 |
| Grant date | Jul 18, 2017 |
| Priority date | — |
| Expiry date | Feb 13, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel cyanopyrimidine compound and a pharmaceutical composition which have a safe and potent adenosine A2a receptor agonistic activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.